TWIST1 and breast carcinoma: To confirm that the cells characterised as CTCs in breast cancer patients were nonhematopoietic cells presenting ectopic cytokeratin expression, we performed triple-immunofluorescence experiments using antibodies against CKs and CD45 along with antibodies against Twist or vimentin.